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https://doi.org/10.1016/j.stemcr.2017.09.018SUMMARYTo interrogate the alternative fates of pancreas and liver in the earliest stages of human organogenesis, we developed laser capture, RNA
amplification, and computational analysis of deep sequencing. Pancreas-enriched gene expression was less conserved between human
and mouse than for liver. The dorsal pancreatic bud was enriched for components of Notch, Wnt, BMP, and FGF signaling, almost all
genes known to cause pancreatic agenesis or hypoplasia, and over 30 unexplored transcription factors. SOX9 and RORA were imputed
as key regulators in pancreas compared with EP300, HNF4A, and FOXA family members in liver. Analyses implied that current in vitro
human stem cell differentiation follows a dorsal rather than a ventral pancreatic program and pointed to additional factors for hepatic
differentiation. In summary, we provide the transcriptional codes regulating the start of human liver and pancreas development to facil-
itate stem cell research and clinical interpretation without inter-species extrapolation.INTRODUCTION
Experiments in mouse and other model organisms have
demonstrated that the pancreas and liver arise as alterna-
tive fates from common progenitors in the distal foregut
(McCracken and Wells, 2012). We know little about the
earliest phases of their organogenesis directly in human
embryos, the period correlating to organ agenesis or severe
hypoplasia in patients. In major part this is due to the tiny
size of the organ buds and the scarcity of post-implantation
human embryonic material. Fresh understanding of hu-
man development has come from genome-wide deep
sequencing (seq) technology. However, the earliest tran-
scriptomic data for pancreas come 7–15 days after the
bud first emerges from the distal foregut by which time
the organ is branched with luminal structures, just prior
to acinar differentiation, and in all likelihood comprised
of heterogeneous progenitor cells (Cebola et al., 2015; Ger-
rard et al., 2016). By this stage, liver development has also
advanced beyond the early bud. There are differences be-
tween the earliest human pancreas and its murine counter-
part, such as lack of the transcription factor (TF), NKX2-2,
and no early phase of endocrine differentiation (‘‘primary
transition’’; Jennings et al., 2013). For this combination
of reasons, we developed approaches to investigate the ge-
netic programs responsible for initiating pancreas and liver
development directly in human embryos.Stem
This is an open access artiRESULTS
LCA-RNA-Seq on Human Embryonic Foregut
Derivatives
Human embryogenesis is categorized by Carnegie stages
(CS), which extend up to 56–58 days post conception
(dpc) (O’Rahilly and Muller, 2010; Table S1). At the start
of the fifth week, pancreatic patterning of the distal foregut
can be discerned (CS12) followed by dorsal pancreatic
outgrowth from CS13 (Jennings et al., 2013). At the same
time, the liver bud is comprised of the first hepatic cords
connected to a hepatobiliary primordium (HBP). We iden-
tified these structures in serial tissue sections in 13 human
embryos from late CS12 to early CS14 and devisedmethod-
ology for laser capture (LC), RNA isolation (including
DNase treatment), amplification (A), and deep sequencing
(LCA-RNA-seq; Figure 1A). LC of 500,000–850,000 mm2 per
tissue type per biological replicate (Table S1) yielded15ng
total RNA for each sample. RNA amplified proportionately
across tissues for genes encoding the TF, FOXA2, or ‘‘house-
keeping’’ protein, GAPDH (Figure S1), and sequencing
yielded similar mapping statistics across tissue types and
replicates (Table S1). To confirm accurate dissection, we
analyzed transcription of PDX1, SOX9, AFP, and ISL1 as
genes with restricted expression profiles. Both PDX1 and
SOX9 were appropriately detected in the pancreas and to
a lesser extent in the HBP (Jennings et al., 2013), whileCell Reports j Vol. 9 j 1–8 j November 14, 2017 j ª 2017 The Authors. 1
cle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. LCA-RNA-Seq of Human Foregut
Derivatives
(A) (Left to right) Human embryo at CS13
(30–33 days post conception [dpc]) with a
sagittal section stained by H&E showing the
boxed area at higher magnification before and
after laser capture (LC). Post LC shows dissec-
tion of the dorsal pancreatic bud (dp), hep-
atobiliary primordium (hbp), and ventral
pancreatic bud (vp)either sideof theduodenum
(d). gb, gallbladder. Insufficient total RNA was
obtained from vp for LCA-RNA-seq. LC of the
hepatic cords (hc) is not shown in this image.
(B) Transcript profiles in two replicates
(1 and 2) for key genes with known restricted
expression across the dissected tissues. Lack
of ISL1 detection indicated no contamina-
tion of dp by mesenchyme (me).
(C) Sagittal sections of a human embryo at
CS14 (33–35 dpc) counterstained with tolu-
idine blue following immunohistochemistry
(brown) for PDX1, SOX9, and ISL1. The boxed
area demonstrates positive ISL1 staining in
adjacent mesenchyme.
Scale bars represent 100 mm.
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effective absence of ISL1 (in total only two reads) specif-
ically excluded contamination of the pancreatic dataset
with mesenchyme (Figures 1B and 1C). GATA4 is present
in perihepatic mesenchyme but not detected in hepato-
blasts or hepatocytes (Jennings et al., 2013). GATA4 tran-
scripts most likely indicated some heterogeneity in the
hepatic cord samples. The most highly expressed genes
across all samples included those encoding several key
liver-specific proteins (e.g., AFP, APOA2, SERPINA1, and
APOB) but also multiple imprinted genes, several of which
transcribed non-coding RNAs (e.g., H19, MALAT1, and
MEG3) (Tables S2A and S2B).
Defining Specific Transcriptional Signatures
Based on their common origin from distal foregut, we
reasoned that comparative analysis would identify the ge-
netic programs responsible for initiating development of
either the pancreas or liver. Pancreas-enriched expression
of TFs, such as NKX6-1, PTF1A, and MNX1, concurred
with their critical developmental roles in mouse (Jennings
et al., 2015; Figures 2A and 2B and Tables S4A and S4C).
Gene ontology (GO) analyses discovered pancreas-en-
riched NOTCH, BMP, andWNTsignaling, similar to mouse
(Rodrı´guez-Seguel et al., 2013) and validating the use of the
relevant ligands when differentiating human pluripotent
stem cells (hPSCs) to pancreatic endoderm (Rezania et al.,
2014; Figure 2C; Table S4A). Despite their primitive appear-2 Stem Cell Reports j Vol. 9 j 1–8 j November 14, 2017ance, the hepatic cords were enriched for metabolic and
biosynthetic processes (Figure 2D and Tables S3A, S3B,
and S4B). Regardless of threshold (reads per kilobase of
transcript per million mapped reads [RPKM] R 0.5, 1.0,
or 10) or whether expression was detected in either or
both sample replicates, exceptionally few genes emerged
as characteristic of the HBP (Figures 2A and 2E); approxi-
mately 4-fold less compared with the dorsal pancreatic
bud and 7-fold less compared with the hepatic cords (Fig-
ure 2E). The most distinguishing was PLXNB3, which
encodes the receptor for Semaphorin 5A. The hepatic
cord datasets sampled local growth factors relevant to
in vitrohPSCdifferentiation towardhepatocytes (Figure 2F).
HGF and FGF2 or -4 are widely used in current protocols. In
fact, heparin-binding growth factor (HDGF), not HGF, was
the most highly expressed by RPKM, while FGF23, not
FGF2 (barely detected) or FGF4 (not detected), was the
most highly detected FGF family member (Figure 2F).
Previously, we have scrutinized the fidelity of pancreatic
differentiation from hPSCs against human pancreas from
later development, after branching, benchmarked mostly
against non-endodermal lineages and without consider-
ation of the hPSC differentiation time course (Cebola
et al., 2015). To analyze differentiation dynamically
against earlier pancreatic development and including
closely related endoderm derivatives, we normalized and
integrated data from sequentially differentiated hPSCs
(Figure 3A; Xie et al., 2013) and undertook principal
Figure 2. Differential Expression and Gene
Ontology Enrichment Across Embryonic
Foregut Outgrowths
(A) Ternary log-fold plot of differential gene
expression (scaled to zero at the center and
a maximum of 1 at each corner) across the
three tissues. Mean plot position for each
gene with EdgeR false discovery rate (FDR)%
0.01 in at least one pairwise comparison is
shown as a gray dot. Selected genes are
highlighted for dorsal pancreatic bud (red),
hepatic cords (blue), and hepatobiliary pri-
mordium (green).
(B) The ten most upregulated transcription
factors (by log-fold change) in dorsal pancre-
atic bud (red) versus hepatic cords (blue).
(C and D) Most significantly enriched GO terms
for dorsal pancreatic bud (C) versus hepatic
cords (D) (FDR <0.0001).
(E) Bar chart and accompanying Eulergrid
showing numbers of genes and the patterns of
their expression across the three tissues.
Green squares indicate genes expressed in
either replicate (defined as >10 reads after
normalization).
(F) Mean RPKM for growth factors detected in
the hepatic cord datasets that are relevant to
hPSC differentiation protocols in vitro.
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PC1 reflected the different sample sources and was unin-
formative (Figure S2). In contrast, PC2 loadings close to
zero identified distal foregut outgrowths. Plotting PC3
against PC2 depicted differentiation from hPSCs to
pancreatic endocrine cells as a U-shape with unique tran-
sient approximation to the native pancreatic bud at the
appropriate stage of in vitro pancreatic endoderm (Fig-
ure 3B). Underlying this proximity was expression of key
pancreatic genes such as ONECUT2, MNX1, and SOX9 as
part of the associated GO term ‘‘endocrine pancreas devel-
opment’’ (Figure 3C; Tables S6 and S7A). In contrast, plot-
ting PC4 and PC3 emphasized the relative deficiency of
the hPSC-derived pancreatic endoderm in gene expression
underlying GO terms for ‘‘cell adhesion’’ and ‘‘cell-cellsignaling’’ and expression of the key pancreatic genes
NKX6-1 and PTF1A (Figure 3D).
Distinct Expression Marks the Human Dorsal and
Ventral Pancreatic Buds
PC3 loadings in Figure 3B clearly separated the dorsal
pancreatic bud from either HPB or hepatic cords with
the GO term for anterior/posterior pattern specification
(Figure 3C; Table S6). This led us to hypothesize that
patterning genes and others with extreme low PC3 load-
ings and absent expression in either hepatic cords or HBP
(Table S2A) might discriminate ventral from dorsal foregut
structures. We identified 13 genes (HOXA1, HOXA2,
HOXC4, SIM1, SEZ6L, DLL1, CDX2, CSMD3, SLITRK2,
CNR1, FRZB, DCC, and ARMC3). Consistent with our LCStem Cell Reports j Vol. 9 j 1–8 j November 14, 2017 3
Figure 3. Comparison of In Vitro hPSC Dif-
ferentiation with Native Human Embry-
onic Development
(A) Schematic overview of in vitro hPSC dif-
ferentiation toward pancreatic beta cells.
(B) Principal components analysis (PCA) of
rank-normalized datasets with sample load-
ings for PC3 plotted against those of PC2
(left) and PC4 (right). The hPSC differentia-
tion transiently approximated to the native
dorsal pancreatic bud at the stage of in vitro
pancreatic endoderm (the lowest PC3 load-
ings and PC2 loadings near zero) (left). In
contrast, PC4 discriminated the native from
in vitro pancreatic cells (right).
(C) The ten most enriched biological process
GO terms for gene expression underlying the
lowest (top panel) and highest (bottom
panel) PC3 loadings, indicative of dorsal
pancreas and hepatic cords, respectively.
(D) Most significantly enriched biological
process GO terms for gene expression
(R10 reads in both replicates) underlying
low PC3 and high PC4 loadings (<0.005
and >0.005), which discriminated native
dorsal pancreatic bud from PSC-derived
pancreatic endoderm.
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hPSCs differentiated to pancreatic endoderm compared
with hepatoblasts/early hepatocytes (Figure 4A). Although
exceptionally limited RNA from the tiny ventral pancreatic
bud precluded LCA-RNA-seq, we isolated sufficient from
four embryos (Table S1) to questionwhether these 13 genes
might also discriminate the dorsal from the ventral pancre-
atic bud. By quantitative (q) RT-PCR, PDX1 was at least as
well expressed in the ventral as in the dorsal bud and
used to normalize the data alongside ACTB. All 13 of our
genes were enriched in the dorsal compared with the
ventral pancreatic bud (Figure 4B). Taken together with
the PC3 loadings, these data imply that hPSCs differentiate
down a dorsal rather than a ventral pancreatic program.Comparison of Early Pancreas and Liver Development
between Human and Mouse
We have previously shown molecular differences between
very early human and mouse pancreas (Jennings et al.,
2013), prompting us to interrogate comparable mouse
transcriptomes from E10.5 (Rodrı´guez-Seguel et al., 2013).
We identified those genes in mouse with enrichment in4 Stem Cell Reports j Vol. 9 j 1–8 j November 14, 2017dorsal pancreas compared with the liver bud (Figure 4C).
Approximately half of the genes also showed clear enrich-
ment in human dorsal pancreatic bud compared with the
hepatic cords. However, a number of genes failed to show
such differential expression (e.g., TXNDC16, SLC29A4, or
CHST2, alongside NKX2-2 as expected; Jennings et al.,
2013) or were more enriched in human liver (e.g.,
DNAHC11, LPAR1, orASAP3). In contrast, most genes upre-
gulated in the mouse liver bud compared with dorsal
pancreas were similarly upregulated in human hepatic
cords (Figure 4D).Transcription Factor Codes Regulating Human
Pancreas and Liver Buds
We scrutinized TF codes in liver and pancreas buds in two
ways. Firstly, we cataloged all TFs in each dataset by expres-
sion level (Table S7A). There were 655 TFs in the pancreatic
bud, 574 in the HBP, and 637 in the hepatic cords. From
this repertoire, we identified those TFs imputed to regulate
the most differentially expressed genes based on known
binding events or motif discovery (Janky et al., 2014).
SOX9 (38% of the top 1,000 pancreas-enriched genes) and
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atic program,while approximately half of themost liver-en-
riched genes were ascribed regulation by FOXA family
members, the transcriptional coactivator EP300 and
HNF4A (Table S7B). In addition, to capture the wider reper-
toire of key pancreatic TFs, we filtered differential expres-
sion between pancreas and liver based on fold change and
significance. This yielded 61 TFs, including virtually all
causes of human pancreatic agenesis or hypoplasia such as
PDX1, PTF1A, and RFX6 (Jennings et al., 2015; Figure 4E).
A further 30% are known to function in pancreas develop-
ment in other species (e.g., NKX6-1 and ONECUT1; Jen-
nings et al., 2015). Over half (57.4%) were previously not
associated with pancreas development, including many
zinc finger TFs (Figure 4E). qRT-PCR for a subset of these fac-
tors showed increased expression as hPSCs underwent
pancreatic endoderm differentiation (Figure 4F).DISCUSSION
We have deciphered the transcriptomic programs regu-
lating the earliest development of the pancreas, liver, and
biliary tree in human embryos.
The HBP transcriptome was relatively undistinctive.
PLXNB3, the most characteristic HBP gene, is among seven
genes on the X chromosome that can be deleted as part of
the Contiguous ABCD1/DXS1375E Deletion Syndrome
(CADDS; OMIM #300475), which includes severe chole-
static jaundice due to obstructed bile flow (Iwasa et al.,
2013). None of the other six genes were enriched in the
HBP, offering PLXNB3 as a plausible regulator of human
bile duct development.
Comprehensive transcriptomic signatures were dis-
cerned for hepatic cords and pancreatic bud. The imputed
regulatory role for SOX9 fits with the pancreatic hypoplasia
observed in campomelic dysplasia (Piper et al., 2002) and
the pancreatic enrichment of WNT, NOTCH, and BMP
signaling pathways, which are known to regulate SOX9
(Figure 2C; Pritchett et al., 2011). The value of our data
will increase as computational tools, such as iRegulon,
add binding information for additional TFs. Our 35 pancre-
atic TFs (Figure 4E) include some that are already net-
worked, such as ZNF503 and ZNF703 as targets of HOXA2
in the branchial arches (Amin et al., 2015). In addition,
genes encoding 15 of the 35 TFs (SIM1, CDX2, GRHL2,
CUX2, KLF5, ZNF503, ID4, ZNF462, ZNF703, ZFP36L2,
MAML3, ZNF704, ZFHX3, ZNF608, and ASXL3) are associ-
ated with cis-regulatory modules controlled by PDX1,
GATA6, FOXA2, HNF1B, and/or ONECUT1 in hPSC-
derived pancreatic endoderm (Cebola et al., 2015).
In liver, current protocols for generating hepatocyte-like
cells from hPSCs result in immature phenotypes (Baxteret al., 2015) implying added factors may not mirror those
from human development. Here, we have demonstrated
HDGF and FGF23 as two factors from human embryogen-
esis for exploration in hPSC protocols. As an alternative
to hPSC differentiation, imputing HNF4A and FOXA fac-
tors as central to the molecular circuitry in the developing
liver concords with their ability to reprogram human fibro-
blasts toward hepatocytes (Huang et al., 2014).
In summary, LCA-RNA-seq has decoded the transcrip-
tomic programs operational at the inception of human
pancreas and liver development. The data are anticipated
to help refine hPSC differentiation protocols, prioritize fac-
tors for programming cell fate, including the potential
interconversion of hepatic and pancreatic cell fate by trans-
differentiation, and understand developmental disorders
in patients. Alongside other studies in later stage embryos
(Cebola et al., 2015; Gerrard et al., 2016), the data pave
the way for a comprehensive genomic atlas of human
organogenesis.EXPERIMENTAL PROCEDURES
Human Tissue, Immunohistochemistry, and
Microdissection
The collection, use, and storage of human embryos (Table S1) from
social termination of pregnancy was carried out as previously (Jen-
nings et al., 2013) with ethical approval from the North West
Research Ethics Committee under the Codes of Practice of the
UK Human Tissue Authority. In brief, human embryos were fixed
within 1 hr in 4% paraformaldehyde (PFA) under RNase-free con-
ditions, processed, and embedded in paraffin wax for orientated
sectioning in either the transverse or sagittal planes at 5 mm inter-
vals. LandmarkH&E stainingwas undertaken every eighth section.
Tracing the correct structures for LC was achieved by immuno-
staining occasional sections (Supplemental Experimental Proced-
ures; Figure 1C). Intervening hematoxylin-stained sections were
then microdissected under 340 objective magnification using a
PALMMicrobeam 3 system (Carl Zeiss GmbH, Germany). Material
was catapulted into a 500 mL AdhesiveCap (Carl Zeiss GmbH, Ger-
many) and stored at 80C.
RNA Extraction, Amplification, and PCR
Total RNA was extracted using the RNeasy FFPE kit (QIAGEN,
Manchester, UK) according to the manufacturer’s instructions,
including DNase treatment. RNA integrity (RNA integrity
number R 7) and quantity were determined using an Agilent
2,100 Bioanalyzer (Agilent Technologies, Palo Alto, CA,USA). Total
RNA (15 ng) was amplified and converted to cDNA using the
Ovation RNA-seq system V2 (NuGEN Technologies, San Carlos,
CA, USA; Dafforn et al., 2004). To assess uniformity of amplifica-
tion, qPCR was performed on samples post amplification (Applied
Biosystems, Life Technologies) and comparedwith qPCR following
RTof unamplified (control) samples (Figure S1). RT and qPCR were
performed as described previously (Baxter et al., 2015; primers
listed in Supplemental Experimental Procedures). Severe materialStem Cell Reports j Vol. 9 j 1–8 j November 14, 2017 5
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pancreatic bud.
Deep Sequencing, Mapping, Quantification, and
Differential Expression
Paired-end sequencing (50 bp) was carried out using an Illumina
HiSeq 2000 at the Wellcome Trust Centre for Human Genetics,
Oxford, UK. Reads were mapped to the GENCODE 15 transcrip-
tome (Harrow et al., 2012) using TopHat version 1.4.1 (Trapnell
et al., 2009). Gene-level transcript abundance (read counts and
RPKM) was estimated by an algorithm implemented in the Partek
Genomics Suite (version 6.6 [6.12.1227]; Partek Inc., St. Louis,
MO, USA) (Tables S2A and S2B). After filtering mitochondrial
genes, ribosomal RNAs, and two other multi-locality RNAs
(Metazoa_SRP and 7SK) the number of mapped reads varied
from zero (for >50% of genes) to >90,000 (e.g., APOB in liver). Dif-
ferential expression was examined in the R/Bioconductor package
EdgeR (version 3.0.8; Robinson et al., 2010) using a generalized
linear model (count = tissue + replicate) and the default trimmed
mean of M values (TMM) scaled differences in library size
(McCarthy et al., 2012). For comparison with pancreatic hPSC
differentiation (Xie et al., 2013), RNA-seq data were retrieved
from ArrayExpress, remapped, and quantified as above. PCA was
performed on the combined rank-normalized gene-level abun-
dances from both datasets. The mouse RNA-seq dataset (GEO:
GSE40823) (Rodrı´guez-Seguel et al., 2013) was downloaded and
remapped to the mm10 genome using STAR (version 2.4.2a; Do-
bin et al., 2013) with gene-level read counts calculated according
to the GENCODEM5 annotation. Human andmouse read counts
were combined by biomaRt (Durinck et al., 2009) using gene i.d.
mappings from Ensembl and quantile normalized. Genes were
filtered for one-to-one orthologs.
Gene Set Enrichment
Sets of genes enriched between the different LCA-RNA-seq datasets
were assessed for GO term enrichment with EdgeR false discovery
rates <104. Fisher’s exact test was applied with the elimination
algorithm as implemented in the topGO R package (version
2.12.0). Additional data and annotationswere obtained fromother
Bioconductor R packages (org.Hs.eg.db [2.9.0], GO.db [2.9.0],
AnnotationDbi [1.22.6]).
Gene-level PCA projected loadings were used to test for GO gene
set enrichment employing one-sided Wilcoxon rank-sum tests to
test separately for enrichment at both ends of the loading distribu-Figure 4. Distinct Expression Patterns Mark Human Dorsal and
Identifies Clinically Important Pancreatic Regulators
(A) Quantitative (q) RT-PCR in hPSC-derived pancreatic endoderm (pa
from low PC3 loadings and absent expression in hepatic cords and HB
(B) qRT-PCR for the same genes in dorsal and ventral pancreatic buds
(C and D) Heatmap of transcripts that showed significant differential
mouse (Rodrı´guez-Seguel et al., 2013) integrated with the human L
expression. Read counts were quantile normalized and scaled to the
(E) Genes encoding transcription factors enriched in the dorsal pancre
and categorized as either known (green and blue) or unrecognized (r
(F) Pancreatic transcription factor gene expression by qRT-PCR during
are shown relative to the definitive endoderm (DE) stage. Error bars rtions. This was implemented within the topGO framework and
used the elimination algorithm to traverse the GO ontologies.
Analysis of Regulation by Transcription Factors
The 1,000 genes most differentially expressed in dorsal pancreas
(logFC > 0) or hepatic cords (logFC < 0) were loaded into Cytoscape
(version 3.2.1.) and used as queries to the iRegulonplug-in (version
1.3, build 1024) (Janky et al., 2014). The default iRegulon parame-
ters search for enrichment of either knownmotifs or experimental
TF binding data within 10 kb of the transcription start sites.
Pancreatic analysis was constrained to motif discovery to over-
come the relative lack of pancreatic binding data in iRegulon
compared with data for hepatocytes. The putative regulators re-
turned from the iRegulon analysis were filtered according to
expression in the LCA-RNA-seq datasets (Table S7B).
hPSC Differentiation
In vitro differentiation of hPSCs to pancreatic endoderm (H9) and
hepatoblast-early hepatocyte-like cells (HUES7) was undertaken
as reported previously (Baxter et al., 2015; Cebola et al., 2015)
with RT-qPCR at 3, 13, 16, and 27 days (pancreatic protocol) and
3, 10, 15, and 30 days (hepatic).
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